You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 21, 2024

Litigation Details for Purdue Pharma L.P. v. Accord Healthcare Inc. (D. Del. 2020)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Purdue Pharma L.P. v. Accord Healthcare Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for Purdue Pharma L.P. v. Accord Healthcare Inc. (D. Del. 2020)

Date Filed Document No. Description Snippet Link To Document
2023-04-11 118 Opinion OxyContin. (DTX-008). 7. United States Patent No. 6,488,963 to McGinity ("McGinity") is prior…of the Mannion '933 patent, claim 3 of the '808 patent, claim 6 of the '886 patent, claims 3 and 11 of…808 patent, and claim 6 of the ' 886 patent. The second group consists of U.S. Patent Nos… ' 933 patent, claim 3 of the ' 808 patent, and claim 6 of the '886 patent. Claim 3 of…Mannion '933 patent at 159:21-22; ' 808 patent at 159:62-63 ; ' 886 patent at 172:30). All External link to document
2023-04-26 126 Judgment quot;the ' 933 patent"), and 9,522,919 ("the ' 919 patent") (D .I. 1); … (5) that claim 21 of U.S. Patent No. 9,522,919 is declared to be invalid on the ground… ' 933 patent, the ' 808 patent, the ' 886 patent, the ' 933 patent, and the '…quot;) infringed U.S . Patent Nos. 9,763 ,933 ("the Mannion ' 933 patent"), 9,775 ,808 (… ("the ' 808 patent"), 9,763 ,886 ("the ' 886 patent"), 9,073 ,933 (" External link to document
2023-04-26 127 Patent/Trademark Report to Commissioner of Patents B2; 9,763,886 B2; 9,073,933 B2; 9,522,919 B2; 10,407,434 B2. (Attachments: # 1 Final Judgment)(nms) (Entered… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,763,933 B2; …2020 26 April 2023 1:20-cv-01362 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2021-03-11 14 Counterclaim AND Answer to Complaint the ‘886 patent”); 9,073,933 (“the ’933 patent”); 9,522,919 (“the ’919 patent”); and 10,407,434 (“the ’…RELIEF (PATENT INFRINGEMENT OF U.S. PATENT NO. 10,407,434) 74. Purdue and…, 2019, the USPTO issued U.S. Patent No. 10,407,434 (“the ‘434 patent), entitled “PROCESS FOR PREPARING…Mannion ‘933 patent, the ‘808 patent, the ‘886 patent, the ‘933 patent, the ‘919 patent, and the ‘434…United States Patent Nos. 9,763,933 (“the Mannion ’933 patent”); 9,775,808 (“the ’808 patent”); 9,763,886 External link to document
2020-10-08 4 Patent/Trademark Report to Commissioner of Patents ; 9,775,808 B2 ; 9,763,886 B2 ; 9,073,933 B2 ; 9,522,919 B2. (kmd) (Entered: 10/08/2020) 8 October… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,763,933 B2 ;…2020 26 April 2023 1:20-cv-01362 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2021-08-31 43 Stipulation-General (See Motion List for Stipulation to Extend Time) terms of U.S. Patent Nos. 8,808,741 (the “’741 patent”), 8,894,987 (the “’987 patent”), and 8,894,988…infringement of U.S. Patent Nos. 9,763,933 (“the Mannion ’933 patent”); 9,775,808 (the “’808 patent”); 9,763,8869,763,886 (the “’886 patent”); 9,073,933 (the “’933 patent”); 9,522,919 (the “’919 patent”) and 10,407,434 …terms of U.S. Patent Nos. 9,492,392 (the “’392 patent”) and 9,492,393 (the “’393 patent”) directed to…terms of U.S. Patent Nos. 9,492,389 (“the ’389 patent”), and 9,492,391 (“the ’391 patent”) directed to External link to document
2022-08-26 82 Redacted Document 9,763,886 (“886 patent”), 9,763,933 (“Mannion 933 patent”), 9,775,808 (“808 patent”), 10,407,434 (“434 patent…of the patents-in-suit: U.S. Patent Nos. 9,073,933 (“933 patent”), 9,522,919 (“919 patent”), 9,763,… 2. The asserted patents fall within two patent families, the “Low 8α/ABUK Patents” (933, 919 and …and 434 patents) and the “Abuse-Deterrent Patents” (Mannion 933, 808 and 886 patents). 3. OxyContin… 1. This is an action for patent infringement under the patent laws of the United States, Title External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.